Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Immunological Risk Stratification of Bladder Cancer Based on Peripheral Blood Natural Killer Cell Biomarkers.

Guillamón CF, Gimeno L, Server G, Martínez-Sánchez MV, Escudero JF, López-Cubillana P, Cabezas-Herrera J, Campillo JA, Abellan DJ, Martínez-García J, Martínez-Escribano J, Ferri B, López-Álvarez MR, Moreno-Alarcón C, Moya-Quiles MR, Muro M, Minguela A.

Eur Urol Oncol. 2019 May 14. pii: S2588-9311(19)30058-6. doi: 10.1016/j.euo.2019.04.009. [Epub ahead of print]

PMID:
31411976
2.

Activating KIRs on Educated NK Cells Support Downregulation of CD226 and Inefficient Tumor Immunosurveillance.

Guillamón CF, Martínez-Sánchez MV, Gimeno L, Campillo JA, Server-Pastor G, Martínez-García J, Martínez-Escribano J, Torroba A, Ferri B, Abellán DJ, Legaz I, López-Álvarez MR, Moya-Quiles MR, Muro M, Minguela A.

Cancer Immunol Res. 2019 Aug;7(8):1307-1317. doi: 10.1158/2326-6066.CIR-18-0847. Epub 2019 Jun 25.

PMID:
31239317
3.

NKG2D Polymorphism in Melanoma Patients from Southeastern Spain.

Gimeno L, Martínez-Banaclocha H, Bernardo MV, Bolarin JM, Marín L, López-Hernández R, López-Alvarez MR, Moya-Quiles MR, Muro M, Frias-Iniesta JF, Martínez-Escribano J, Alvarez-López MR, Minguela A, Campillo JA.

Cancers (Basel). 2019 Mar 28;11(4). pii: E438. doi: 10.3390/cancers11040438.

4.

High-resolution characterization of allelic and haplotypic HLA frequency distribution in a Spanish population using high-throughput next-generation sequencing.

Montero-Martín G, Mallempati KC, Gangavarapu S, Sánchez-Gordo F, Herrero-Mata MJ, Balas A, Vicario JL, Sánchez-García F, González-Escribano MF, Muro M, Moya-Quiles MR, González-Fernández R, Ocejo-Vinyals JG, Marín L, Creary LE, Osoegawa K, Vayntrub T, Caro-Oleas JL, Vilches C, Planelles D, Fernández-Viña MA.

Hum Immunol. 2019 Jul;80(7):429-436. doi: 10.1016/j.humimm.2019.02.005. Epub 2019 Feb 11.

PMID:
30763600
5.

NK Cell Education in Tumor Immune Surveillance: DNAM-1/KIR Receptor Ratios as Predictive Biomarkers for Solid Tumor Outcome.

Guillamón CF, Martínez-Sánchez MV, Gimeno L, Mrowiec A, Martínez-García J, Server-Pastor G, Martínez-Escribano J, Torroba A, Ferri B, Abellán D, Campillo JA, Legaz I, López-Álvarez MR, Moya-Quiles MR, Muro M, Minguela A.

Cancer Immunol Res. 2018 Dec;6(12):1537-1547. doi: 10.1158/2326-6066.CIR-18-0022. Epub 2018 Sep 21.

PMID:
30242020
6.

In vitro intracellular IFNγ, IL-17 and IL-10 producing T cells correlates with the occurrence of post-transplant opportunistic infection in liver and kidney recipients.

Boix F, Llorente S, Eguía J, Gonzalez-Martinez G, Alfaro R, Galián JA, Campillo JA, Moya-Quiles MR, Minguela A, Pons JA, Muro M.

World J Transplant. 2018 Feb 24;8(1):23-37. doi: 10.5500/wjt.v8.i1.23.

7.

Three new HLA class I alleles with synonymous mutations: HLA-A*03:01:62, -C*07:02:82 and -C*12:03:42.

Moya-Quiles MR, Balas A, Muro M, García-Alonso AM, Vicario JL.

HLA. 2018 Jan;91(1):60-61. doi: 10.1111/tan.13163. Epub 2017 Nov 10.

PMID:
29064189
8.

CD28 biomarker quantification and expression level profiles in CD4+ T-lymphocytes in solid organ transplantation.

Boix F, Bolarín JM, Mrowiec A, Eguía J, Gonzalez-Martinez G, de la Peña J, Galian JA, Alfaro R, Moya-Quiles MR, Legaz I, Campillo JA, Ramírez P, García-Alonso A, Pons JA, Sánchez-Bueno F, Minguela A, Llorente S, Muro M.

Transpl Immunol. 2017 Jun;42:9-17. doi: 10.1016/j.trim.2017.04.001. Epub 2017 Apr 6.

PMID:
28392336
9.

Pretransplant CD28 Biomarker (Levels of Expression and Quantification of Molecules per Cell) in Peripheral CD4+ T Cells Predicts Acute Rejection Episodes in Liver and Kidney Recipients.

Boix F, Bolarín JM, Eguía J, Gonzalez-Martinez G, De La Peña J, Galian JA, Hernández-Martínez AM, Moya-Quiles MR, Legaz I, Campillo JA, Ramirez P, Sanchez-Bueno F, García-Alonso AM, Pons JA, Minguela A, Llorente S, Muro M.

Transplant Proc. 2016 Nov;48(9):2987-2989. doi: 10.1016/j.transproceed.2016.09.028.

PMID:
27932126
10.

Killer immunoglobulin-like receptor repertoire analysis in a Caucasian Spanish cohort with inflammatory bowel disease.

López-Hernández R, Campillo JA, Legaz I, Valdés M, Salama H, Boix F, Hernández-Martínez AM, Eguia J, González-Martínez G, Moya-Quiles MR, Minguela A, García-Alonso A, Carballo F, Muro M.

Microbiol Immunol. 2016 Nov;60(11):787-792. doi: 10.1111/1348-0421.12447.

11.

Humoral Response in Liver Allograft Transplantation: A Review of the Role of Anti-Human Leukocyte Antigen (HLA) Antibodies.

Muro M, Moya-Quiles MR, Mrowiec A.

Curr Protein Pept Sci. 2016;17(8):776-784. Review.

PMID:
26916161
12.

Dock10 regulates CD23 expression and sustains B-cell lymphopoiesis in secondary lymphoid tissue.

García-Serna AM, Alcaraz-García MJ, Ruiz-Lafuente N, Sebastián-Ruiz S, Martínez CM, Moya-Quiles MR, Minguela A, García-Alonso AM, Martín-Orozco E, Parrado A.

Immunobiology. 2016 Dec;221(12):1343-1350. doi: 10.1016/j.imbio.2016.07.015. Epub 2016 Aug 2.

PMID:
27502165
13.

HLA Epitopes and Shared Molecular Eplet Characterization and Their Implication on Transplant Outcome: The Experience of One Center.

Bosch A, Eguia J, Boix F, López M, González-Martinez G, Galian JA, Moya-Quiles MR, Llorente S, Muro M.

Clin Transpl. 2016;32:73-82.

PMID:
28564524
14.

Dock10, a Cdc42 and Rac1 GEF, induces loss of elongation, filopodia, and ruffles in cervical cancer epithelial HeLa cells.

Ruiz-Lafuente N, Alcaraz-García MJ, García-Serna AM, Sebastián-Ruiz S, Moya-Quiles MR, García-Alonso AM, Parrado A.

Biol Open. 2015 Apr 10;4(5):627-35. doi: 10.1242/bio.20149050.

15.

MHC class I chain-related gene a diversity in patients with cutaneous malignant melanoma from southeastern Spain.

Campillo JA, López-Hernández R, Martínez-Banaclocha H, Bolarín JM, Gimeno L, Mrowiec A, López M, Las Heras B, Minguela A, Moya-Quiles MR, Legáz I, Frías-Iniesta JF, García-Alonso AM, Álvarez-López MR, Martínez-Escribano JA, Muro M.

Dis Markers. 2015;2015:831864. doi: 10.1155/2015/831864. Epub 2015 Mar 9.

16.

Pro- and anti-inflammatory cytokine gene single-nucleotide polymorphisms in inflammatory bowel disease.

López-Hernández R, Valdés M, Campillo JA, Martínez-García P, Salama H, Bolarin JM, Martínez H, Moya-Quiles MR, Minguela A, Sánchez-Torres A, Botella C, Salgado G, Miras M, Carballo F, Muro M.

Int J Immunogenet. 2015 Feb;42(1):38-45. doi: 10.1111/iji.12160. Epub 2014 Oct 31.

PMID:
25359546
17.

Donor specific antibodies median fluorescence intensity levels are the best indicator for monitoring desensitization treatment in kidney transplant.

Boix F, Llorente S, Mrowiec A, Eguia J, López-Hernández R, Bernardo MV, Moya-Quiles MR, Campillo JA, Minguela A, Jimeno L, Alvarez-López MR, Muro M.

Urol J. 2014 Jul 8;11(3):1695-8. No abstract available.

18.

HLA-C antibodies are associated with irreversible rejection in kidney transplantation: Shared molecular eplets characterization.

Bosch A, Llorente S, Eguia J, Mrowiec A, Boix F, López-Hernández R, Campillo JA, Salgado G, Moya-Quiles MR, Minguela A, Jimeno L, Alvarez-López MR, Muro M.

Hum Immunol. 2014 Apr;75(4):338-41. doi: 10.1016/j.humimm.2014.01.010. Epub 2014 Jan 30.

PMID:
24486575
19.

Severe combined immunodeficiency: first report of a de novo mutation in the IL2RG gene in a boy conceived by in vitro fertilization.

Moya-Quiles MR, Bernardo-Pisa MV, Menasalvas A, Alfayate S, Fuster JL, Boix F, Salgado G, Muro M, Minguela A, Alvarez-López MR, García-Alonso AM.

Clin Genet. 2014 May;85(5):500-1. doi: 10.1111/cge.12208. Epub 2013 Jun 24. No abstract available.

PMID:
23790094
20.

Genetic polymorphisms of tumour necrosis factor alpha (TNF-α) promoter gene and response to TNF-α inhibitors in Spanish patients with inflammatory bowel disease.

López-Hernández R, Valdés M, Campillo JA, Martínez-Garcia P, Salama H, Salgado G, Boix F, Moya-Quiles MR, Minguela A, Sánchez-Torres A, Miras M, Garcia A, Carballo F, Álvarez-López MR, Muro M.

Int J Immunogenet. 2014 Feb;41(1):63-8. doi: 10.1111/iji.12059. Epub 2013 Apr 17.

PMID:
23590430
21.

Complement component C6 deficiency in a Spanish family: implications for clinical and molecular diagnosis.

Moya-Quiles MR, Bernardo-Pisa MV, Martínez P, Gimeno L, Bosch A, Salgado G, Martínez-Banaclocha H, Eguia J, Campillo JA, Muro M, Vidal-Bugallo JB, Alvarez-López MR, García-Alonso AM.

Gene. 2013 May 25;521(1):204-6. doi: 10.1016/j.gene.2013.03.027. Epub 2013 Mar 26.

PMID:
23537992
22.

KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury.

Legaz I, López-Álvarez MR, Campillo JA, Moya-Quiles MR, Bolarín JM, de la Peña J, Salgado G, Gimeno L, García-Alonso AM, Muro M, Miras M, Alonso C, Álvarez-López MR, Minguela A.

Transplantation. 2013 Apr 27;95(8):1037-44. doi: 10.1097/TP.0b013e318286486c.

PMID:
23478359
23.

KIR gene variability in cutaneous malignant melanoma: influence of KIR2D/HLA-C pairings on disease susceptibility and prognosis.

Campillo JA, Legaz I, López-Álvarez MR, Bolarín JM, Las Heras B, Muro M, Minguela A, Moya-Quiles MR, Blanco-García R, Martínez-Banaclocha H, García-Alonso AM, Alvarez-López MR, Martínez-Escribano JA.

Immunogenetics. 2013 May;65(5):333-43. doi: 10.1007/s00251-013-0682-0. Epub 2013 Jan 31.

PMID:
23370861
24.

HLA-DRB1 and HLA-DQB1 genes on susceptibility to and protection from allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.

Muro M, Mondejar-López P, Moya-Quiles MR, Salgado G, Pastor-Vivero MD, Lopez-Hernandez R, Boix F, Campillo JA, Minguela A, Garcia-Alonso A, Sánchez-Solís M, Álvarez-López MR.

Microbiol Immunol. 2013 Mar;57(3):193-7. doi: 10.1111/1348-0421.12020.

25.

C1q-fixing human leukocyte antigen assay in immunized renal patients: correlation between Luminex SAB-C1q and SAB-IgG.

Llorente S, Boix F, Eguia J, López M, Bosch A, Martinez H, Gonzalez MJ, López-Hernández R, Salgado G, Moya-Quiles MR, Campillo JA, García-Alonso AM, Minguela A, Jimeno L, Alvarez-López MR, Muro M.

Transplant Proc. 2012 Nov;44(9):2535-7. doi: 10.1016/j.transproceed.2012.09.084.

PMID:
23146446
26.

Low median fluorescence intensity could be a nonsafety concept of immunologic risk evaluation in patients with shared molecular eplets in kidney transplantation.

Bosch A, Llorente S, Diaz JA, Salgado G, López M, Boix F, López-Hernández R, González-Soriano MJ, Campillo JA, Moya-Quiles MR, Perez-Lopez N, Minguela A, Jimeno L, Alvarez-López MR, Muro M.

Hum Immunol. 2012 May;73(5):522-5. doi: 10.1016/j.humimm.2012.02.020. Epub 2012 Mar 6.

PMID:
22425738
27.

Rapp-Hodgkin syndrome and SHFM1 patients: delineating the p63-Dlx5/Dlx6 pathway.

Vera-Carbonell A, Moya-Quiles MR, Ballesta-Martínez M, López-González V, Bafallíu JA, Guillén-Navarro E, López-Expósito I.

Gene. 2012 Apr 15;497(2):292-7. doi: 10.1016/j.gene.2012.01.088. Epub 2012 Feb 9.

PMID:
22342398
28.

Evolution of soluble forms of CD86, CD95 and CD95L molecules in liver transplant recipients.

Marín LA, Moya-Quiles MR, Miras M, Minguela A, Bermejo J, Ramírez P, García-Alonso AM, Parrilla P, Alvarez-López MR, Muro M.

Transpl Immunol. 2012 Mar;26(2-3):94-100. doi: 10.1016/j.trim.2011.12.001. Epub 2011 Dec 13.

PMID:
22182632
29.

[Expanded newborn screening in the Region of Murcia, Spain. Three-years experience].

Juan-Fita MJ, Egea-Mellado JM, González-Gallego I, Moya-Quiles MR, Fernández-Sánchez A.

Med Clin (Barc). 2012 Dec 1;139(13):566-71. doi: 10.1016/j.medcli.2011.10.007. Epub 2011 Dec 3. Spanish.

PMID:
22137990
30.

Influence of human leukocyte antigen mismatching on rejection development and allograft survival in liver transplantation: is the relevance of HLA-A locus matching being underestimated?

Muro M, López-Álvarez MR, Campillo JA, Marin L, Moya-Quiles MR, Bolarín JM, Botella C, Salgado G, Martínez P, Sánchez-Bueno F, López-Hernández R, Boix F, Bosch A, Martínez H, de la Peña-Moral JM, Pérez N, Robles R, García-Alonso AM, Minguela A, Miras M, Alvarez-López MR.

Transpl Immunol. 2012 Mar;26(2-3):88-93. doi: 10.1016/j.trim.2011.11.006. Epub 2011 Nov 23.

PMID:
22129495
31.

A compound heterozygous mutation in the EDAR gene in a Spanish family with autosomal recessive hypohidrotic ectodermal dysplasia.

Moya-Quiles MR, Ballesta-Martínez MJ, López-González V, Glover G, Guillén-Navarro E.

Arch Dermatol Res. 2010 May;302(4):307-10. doi: 10.1007/s00403-009-1013-z. Epub 2009 Dec 24.

PMID:
20033817
32.

HLA-C matching and liver transplants: donor-recipient genotypes influence early outcome and CD8+KIR2D+ T-cells recuperation.

López-Alvarez MR, Moya-Quiles MR, Minguela A, Gil J, Miras M, Campillo JA, Díaz-Alderete MA, García-Alonso AM, Sánchez-Bueno F, Vicario JL, Muro M, Alvarez-López MR.

Transplantation. 2009 Aug 15;88(3 Suppl):S54-61. doi: 10.1097/TP.0b013e3181af7d84.

PMID:
19667963
33.

CFTR mutations in cystic fibrosis patients from Murcia region (southeastern Spain): implications for genetic testing.

Moya-Quiles MR, Mondéjar-López P, Pastor-Vivero MD, González-Gallego I, Juan-Fita MJ, Egea-Mellado JM, Carbonell P, Casals T, Fernández-Sánchez A, Sánchez-Solís M, Glover G.

Clin Genet. 2009 Dec;76(6):577-9. doi: 10.1111/j.1399-0004.2009.01252.x. Epub 2009 Oct 21. No abstract available.

PMID:
19845690
34.

CFTR H609R mutation in Ecuadorian patients with cystic fibrosis.

Moya-Quiles MR, Glover G, Mondéjar-López P, Pastor-Vivero MD, Fernández-Sánchez A, Sánchez-Solís M.

J Cyst Fibros. 2009 Jul;8(4):280-1. doi: 10.1016/j.jcf.2009.05.001. Epub 2009 May 19.

35.

Genetic relationship between Murcia Region (SE Spain) and other populations in the Iberian Peninsula and Mediterranean area with respect to HFE gene mutations distribution.

Muro M, Moya-Quiles MR, Botella C, García L, Minguela A, Alvarez-López MR.

Ann Hematol. 2007 Jun;86(6):455-7. Epub 2007 Jan 18. No abstract available.

PMID:
17235517
36.

[Descriptive study of activity of the bone marrow donor registry and bank from the Murcia Region (southeast of Spain) (1994-2004)].

Rojas Montero GM, Alvarez López MR, López Bermejo A, Moya Quiles MR, Muro Amador M.

An Med Interna. 2006 Nov;23(11):525-8. Spanish.

PMID:
17222067
37.

Impact of recipient HLA-C in liver transplant: a protective effect of HLA-Cw*07 on acute rejection.

Moya-Quiles MR, Alvarez R, Miras M, Gomez-Mateo J, Lopez-Alvarez MR, Marin-Moreno I, Martínez-Barba E, Sanchez-Mozo MP, Gomez M, Arnal F, Sanchez-Bueno F, Marin LA, Garcia-Alonso AM, Minguela A, Muro M, Parrilla P, Alonso C, Alvarez-López MR; Spanish Group of Transplant Immunology and Immunotolerance (G03/104).

Hum Immunol. 2007 Jan;68(1):51-8. Epub 2006 Nov 13.

PMID:
17207712
38.

Prevalence of C282Y, H63D and S65C mutations of the hemochromatosis (HFE) gene in a population from southeastern Spain (Murcia Region).

Muro M, Moya-Quiles MR, Botella C, Alvarez-López MR.

Clin Genet. 2007 Jan;71(1):97-8. No abstract available.

PMID:
17204056
39.

TGF-beta1 gene polymorphism in liver graft recipients.

Gómez-Mateo J, Marin L, López-Alvarez MR, Moya-Quiles MR, Miras M, Marin-Moreno I, Botella C, Parrilla P, Alvarez-López MR, Muro M.

Transpl Immunol. 2006 Dec;17(1):55-7. Epub 2006 Sep 28.

PMID:
17157217
40.

HBV and HCV infections and acute rejection differentially modulate CD95 and CD28 expression on peripheral blood lymphocytes after liver transplantation.

Minguela A, Miras M, Bermejo J, Sánchez-Bueno F, López-Alvarez MR, Moya-Quiles MR, Muro M, Ontañón J, Garía-Alonso AM, Parrilla P, Alvarez-López MR.

Hum Immunol. 2006 Nov;67(11):884-93. Epub 2006 Jul 28.

PMID:
17145368
41.

Human leucocyte antigen-C in B chronic lymphocytic leukaemia.

Montes-Ares O, Moya-Quiles MR, Montes-Casado M, Guerra-Pérez N, Campillo JA, González C, López-Bermejo A, Tamayo M, Majado MJ, Parrado A, Muro M, Marín L, Alvarez-López MR.

Br J Haematol. 2006 Nov;135(4):517-9. Epub 2006 Oct 10.

PMID:
17054674
42.

Natural killer receptors on CD8 T cells and natural killer cells from different HLA-C phenotypes in melanoma patients.

Campillo JA, Martínez-Escribano JA, Moya-Quiles MR, Marín LA, Muro M, Guerra N, Parrado A, Campos M, Frías JF, Minguela A, García-Alonso AM, Alvarez-López MR.

Clin Cancer Res. 2006 Aug 15;12(16):4822-31.

43.

Study of Fas (CD95) and FasL (CD178) polymorphisms in liver transplant recipients.

Marín LA, Muro M, Moya-Quiles MR, Miras M, Minguela A, Bermejo J, Sanchez-Bueno F, Parrilla P, Alvarez-López MR.

Tissue Antigens. 2006 Feb;67(2):117-26.

PMID:
16441482
44.

Evaluation of CD86 gene polymorphism at +1057 position in liver transplant recipients.

Marín LA, Moya-Quiles MR, Miras M, Muro M, Minguela A, Bermejo J, Ramírez P, García-Alonso AM, Parrilla P, Alvarez-López MR.

Transpl Immunol. 2005 Oct;15(1):69-74.

PMID:
16223675
45.

Lack of association between HLA-E polymorphism and primary cutaneous melanoma in Spanish patients.

Moya-Quiles MR, Martínez-Escribano J, Guerra-Perez N, Muro M, Marín L, Campillo JA, Montes-Ares O, Frias J, Minguela A, García-Alonso AM, Lozano JA, Alvarez-López MR.

J Dermatol Sci. 2005 Oct;40(1):62-4. No abstract available.

PMID:
16153808
46.

Acute vascular rejection mediated by HLA antibodies in a cadaveric kidney recipient: discrepancies between FlowPRA, ELISA and CDC vs luminex screening.

Muro M, Llorente S, Marín L, Moya-Quiles MR, Gonzalez-Soriano MJ, Prieto A, Gimeno L, Alvarez-López MR.

Nephrol Dial Transplant. 2005 Jan;20(1):223-6. No abstract available.

PMID:
15632356
47.

The promyelocytic leukemia zinc finger protein down-regulates apoptosis and expression of the proapoptotic BID protein in lymphocytes.

Parrado A, Robledo M, Moya-Quiles MR, Marín LA, Chomienne C, Padua RA, Alvarez-López MR.

Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1898-903. Epub 2004 Feb 9.

48.

Relationship between CDC cross-match in liver recipients and antibody screening by flow cytometry.

Muro M, Sánchez-Bueno F, Marín L, Torío A, Moya-Quiles MR, Minguela A, Montes O, Guerra N, Montes M, Pérez-López MJ, Robles R, Ramirez P, García-Alonso AM, Parrilla P, Alvarez-López MR.

Transplant Proc. 2003 Aug;35(5):1894-5.

PMID:
12962837
49.

Impact of HLA-C on acute rejection in liver transplantation.

Moya-Quiles MR, Torío A, Muro M, Montes-Ares O, Marin L, Minguela A, Sánchez-Bueno F, Garcia-Alonso AM, Parrilla P, Alvarez-López MR.

Transplant Proc. 2003 Aug;35(5):1892-3.

PMID:
12962836
50.

HLA class II genotypic frequencies in atopic asthma: association of DRB1*01-DQB1*0501 genotype with Artemisia vulgaris allergic asthma.

Torío A, Sánchez-Guerrero I, Muro M, Villar LM, Minguela A, Marín L, Moya-Quiles MR, Montes-Ares O, Pagán J, Alvarez-López MR.

Hum Immunol. 2003 Aug;64(8):811-5.

PMID:
12878360

Supplemental Content

Loading ...
Support Center